KDIGO 2012: Anemia in CKD

Zusammenfassung

VOLUME 2 | ISSUE 4 | AUGUST 2 2012 http://www.kidney-international.org OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF NEPHROLOGY KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease KI_SuppCover_2.4.indd 1KI_SuppCover_2.4.indd 17/11/12 12:00 PM7/11/12 12:00 PM KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease KDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen, Bayer Schering Pharma,

Kerninformationen

GRADE system for grading quality of evidence320 Table 13. Final grade for overall quality of evidence320 Table 14. Balance of benefits and harm321 Table 15. KDIGO nomenclature and description for grading recommendations321 Table 16. Determinants of strength of recommendation321 Table 17. The Confere...

Lymphocytotoxic antibody reactivity against random donor test panel in relation to the number of blood transfusions 313 Figure 4. Algorithms for red cell transfusion use in CKD patients315 Additional information in the form of supplementary materials can be found online at http://www.kdigo.org/clini...

CLowThe true effect may be substantially different from the estimate of the effect. DVery LowThe estimate of effect is very uncertain, and often will be far from the truth. CURRENT CHRONIC KIDNEY DISEASE (CKD) NOMENCLATURE USED BY KDIGO CKD CategoriesDefinition CKDCKD of any stage (1–5), with or wit...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen